Drug Metabolism Flashcards
Drug metabolism
Chemical transformation of venobiotic (i.e. drug) within living organism
Most drugs: enzyme based
Some drugs: non-enzyme based
Enzymes usually found in hepatocytes
Inactivation
Lipid soluble (hydrophobic) -> less lipid soluble (hydrophilic) Facilitate excretion via kidney (decreases liklihood it will be reabsorbed by tubule so it will stay in urine and be excreted)
Activation
Inactive drug-active form
Ex: L-dopa -> active dopamine
Clopidogrel (inactive prodrug) -> active metabolite
Major site of biotransformation
ER of hepatocytes in the liver
Phase I reactions
Introducing/exposing a new functional group
Amines, hydroxyls, sulfhydrals
Phase II reactions
Conjugation reaction
Large molecule gets conjugated onto the functional group
Glucuronic acid, glutathione, sulfate group, acetyl group
Most phase II enzymes are in the cytoplasm, but some can be in ER
Microsomal Oxidations
Phase I reactions
Cytochrome P450 enzymes
OXIDATIVE reaction (O2 gets incorporated into drug molecule as hydroxyl group, the other into water)
Mainly found in ER (in liver and intestine)
Mixed-function oxidase system
There is promiscuity between P450 isoforms
NADPH is involved
Non-microsomal oxidations
Phase I reactions
No CYP450
Ex. Alcohol oxidation
Alcohol dehydrogenase (in cytosol), acetaldehyde dehdrogenase (in mitochondria)
(remember there is a cyp that metabolizes alcohol, but its not as important as alcohol dehydrogenase)
Hydrolysis
Phase I reactions
Requires water
Esterases and Amidases
PABA is a common metabolite
Clinical significance: PABA is structually similar to sulfanilamide (anti-microbial) and thus drugs that metabolize to PABA can compete wtih it. Decreases anti-microbial effects of sulfanilamide
Conjugations
Phase II reactions
Functional group from phase I combines with endogenous substrate Flucuronic acid conjugation Acetylation Sulfation Flutathione conjugation
Induction of Drug Metabolism
Typically involved CYP450s Enhanced rate of synthesis or reduced rate of degradation = increased activity of the enzymes Inducing factors: - Environmental pollutants -Tobacco smoke -Char-broiled meat Clinical significance: Altered dosing
Inhibition of Drug Metabolism
Competeitive: one drug can compete for enzyme with co-administered drug. REVERSIBLE
Non-competetive: permanent inhibition of enzyme, covalent modification. IRREVERSIBLE. Protein needs to be resynthesized
Active drug
(Parent drug)
- Very lipid-soluble
- Less polar
- Less ionized
- Weak electrolyte
- More able to penetrate membrane
Inactive drug
(Drug metabolite)
- Less lipid-soluble
- More polar
- More ionized
- Strong electrolyte
- Less able to penetrate cell membrane